By Kamal Choudhury and Christy Santhosh
(Reuters) -The U.S. Food and Drug Administration on Thursday approved Kura Oncology and Japanese partner Kyowa Kirin's once-daily pill, Komzifti, to treat a rare form of blood cancer that has returned or stopped responding to treatment.
The drug is approved for acute myeloid leukemia patients with an NPM1 mutation, a genetic change found in about 30% of cases.
Acute myeloid leukemia is an aggressive cancer of the blood and bone marrow.
Kura said the drug will be available within the next few business days at a price of $48,500 for a one-month supply.
With the approval, Kura's drug now competes with Syndax Pharmaceuticals' Revuforj, which was approved for the same indication by the FDA last month.
Komzifti’s approval comes with a boxed warning for differentiation syndrome and an additional warning for QTc interval prolongation, a delay in the heart’s electrical recovery after a beat, and potential harm to unborn babies.
A boxed warning is the U.S. Food and Drug Administration’s strongest alert for serious or life-threatening risks and appears prominently on a drug’s label to warn doctors and patients.
Revuforj carries a boxed warning for QTc interval prolongation, giving Kura “a significant competitive advantage,” according to Wedbush analysts.
Kura's Chief Medical Officer Mollie Leoni said the risk of QTc prolongation with Komzifti is low, adding it is “extraordinarily unlikely” to lead to a boxed warning.
The company said it is in dialogue with the FDA about potential steps post-approval that could help refine the labeling.
Under the terms of its collaboration with Kyowa, Kura is responsible for manufacturing Komzifti and will lead commercialization in the United States, while Kyowa handles commercial strategy and development outside the U.S.
Analysts, on average, expect Komzifti to have annual sales of $1.32 billion by 2031, according to LSEG data.
(Reporting by Kamal Choudhury and Christy Santhosh in Bengaluru; Editing by Shailesh Kuber and Tasim Zahid)
LATEST POSTS
- 1
Focus on Yourself: Wellbeing and Taking care of oneself Practices - 2Study casts doubt on potential for life on Jupiter's moon Europa
- 3Getting through a Lifelong Change: Individual Examples of overcoming adversity
- 4Comet MAPS faces a make-or-break moment as it dives toward the sun on April 4 — could it shine in the daytime sky?
- 5The Best Portable Applications for Psychological wellness and Prosperity
- April's full moon decides the date of Easter — here's how it works
- A Manual for the Right SUV for Seniors
- Sophie Kinsella, 'Confessions of a Shopaholic' author, dies at 55 after battle with cancer
- See the 'amazing' photos of Earth taken on historic Artemis II moon mission
- What will the Artemis 2 astronauts eat during their historic moon mission? (video)
- Instructions to Pick the Right Dental Embed Trained professional: An Exhaustive Aide
- UK consumer confidence plunges amid escalating Iran conflict
- A definitive Manual for Internet Mastering and Expertise Improvement
- The Leonid meteor shower is peaking early this week. Here’s what to know
